首页> Journal of nuclear medicine : official publication, Society of Nuclear Medicine> Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.

Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands.

导出 OA

翻译打印收藏纠错

第一作者： Donatienne,Van Weehaeghe

第一单位： Nuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium donatienne.vanweehaeghe@uzleuven.be.

作者： Donatienne,Van Weehaeghe ^[1] ; Suma,Babu ^[2] ; Joke,De Vocht ^[3] ; Nicole R,Zürcher ^[4] ; Sheena,Chew ^[2] ; Chieh-En J,Tseng ^[4] ; Marco L,Loggia ^[4] ; Michel,Koole ^[5] ; Ahmadreza,Rezaei ^[5] ; Georg,Schramm ^[5] ; Philip,Van Damme ^[3] ; Jacob M,Hooker ^[4] ; Koen,Van Laere ^[5] ; Nazem,Atassi ^[2]

作者单位： Nuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium donatienne.vanweehaeghe@uzleuven.be. ^[1] Department of Neurology, Sean M. Healey and AMG Center for ALS, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. ^[2] Department of Neurology, University Hospital Leuven, and Laboratory of Neurobiology, Center for Brain and Disease Research, VIB, Leuven, Belgium; and. ^[3] Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts. ^[4] Nuclear Medicine Subdivision, Department of Imaging and Pathology, University Hospital Leuven, Leuven, Belgium. ^[5]

关键词 11C-PBR28 18F-DPA714 amyotrophic lateral sclerosis multicenter translocator protein